The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality and morbidity in the large global population. Advancements in nanotechnology and immunotherapy are revolutionizing how we combat diseases, offering more effective and targeted prevention strategies. These advances will further help to enhance public health and well-being around the world and, at the same time, create valuable commercial opportunities for the industry.
Related Ins(AI)ghts
Related Tags
About SG Analytics
SG Analytics is a leading global data solutions firm providing data-centric research and contextual analytics services to its clients, including Fortune 500 companies, across the Financial Services, Technology, Media & Entertainment, and Healthcare sectors. Established in 2007 and a Great Place to Work certified company, SGA has over 1600 employees and has a presence across the US, the UK, Switzerland, Poland, and India.
Besides being recognized by analyst firms such as Gartner, Everest Group, and ISG, SGA has been part of the elite Deloitte Technology Fast 50 India 2024 and APAC (Asia Pacific) 2025 High Growth Companies by the Financial Times & Statista.